Latest News about BMY
Recent news which mentions BMY
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
From Benzinga
From Benzinga
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029
March 07, 2024
From Benzinga
From InvestorPlace
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
March 05, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
From Benzinga
Bristol-Myers Squibb's Options Frenzy: What You Need to Know
March 04, 2024
Tickers
BMY
From Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
From InvestorPlace
Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss
February 28, 2024
From Benzinga
3 Highly Rated Biotech Stocks to Buy for 300% Gains
February 26, 2024
From InvestorPlace
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
February 22, 2024
Tickers
BMY
From Benzinga
Mental Health Mavericks: 3 Stocks Changing the Game
February 21, 2024
From InvestorPlace
The 3 Best Stocks Beginning Investors Can Buy: February 2024
February 21, 2024
From InvestorPlace
Got $5,000? These 3 Stocks Are Dirt Cheap Buys With Plenty of Upside
February 21, 2024
From Motley Fool
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
February 20, 2024
From Benzinga
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 17, 2024
From Motley Fool
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
From InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
February 14, 2024
From Benzinga
7 Dividend Stocks to Buy at a 52-Week Low
February 12, 2024
From InvestorPlace
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
February 09, 2024
Tickers
BMY
From Benzinga
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
February 09, 2024
From Benzinga
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
From InvestorPlace
3 Blue-Chip Stocks to Buy at a 52-Week Low in February
February 07, 2024
From InvestorPlace
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
From Benzinga
Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 06, 2024
From Benzinga
Bristol-Myers Squibb Options Trading: A Deep Dive into Market Sentiment
February 05, 2024
Tickers
BMY
From Benzinga
Undervalued Gems: 7 Stocks Set for a Major Rebound
February 05, 2024
From InvestorPlace
Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript
February 02, 2024
Tickers
BMY
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.